A new test that identifies seven distinct types of breast cancer could be available within two years, offering hope of personalised treatments to women with the disease, British scientists say.

A team led by Andy Green of the University of Nottingham has developed a method that screens for 10 key proteins that identify seven different biological types of breast cancer.

The technology needed to measure the proteins in tumour samples already exists in most pathology laboratories across the UK, Green said.